Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

5 terminated/withdrawn out of 35 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

40%

8 of 20 completed trials have results

Key Signals

3 recruiting8 with results

Enrollment Performance

Analytics

N/A

20(71.4%)

Phase 4

4(14.3%)

Phase 2

3(10.7%)

Early Phase 1

1(3.6%)

28Total

N/A(20)

Phase 4(4)

Phase 2(3)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials

NCT04244630Phase 2Recruiting

Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial

Role: lead

NCT05220202Not ApplicableRecruiting

MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

Role: collaborator

NCT04571619Phase 2Completed

HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

Role: collaborator

NCT04529083Not ApplicableCompleted

Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation

Role: lead

NCT03896035Not ApplicableCompleted

Improving Outcomes for Older Veterans With Chronic Back Pain and Depression

Role: collaborator

NCT03484403Not ApplicableCompleted

Benefit of Lumbar Bracing for Chronic Low Back Pain Due to Degenerative Disc Disease

Role: lead

NCT01156155Completed

Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis

Role: collaborator

NCT02579460Not ApplicableCompleted

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

Role: lead

NCT02688114Not ApplicableCompleted

Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus

Role: lead

NCT05209724Not ApplicableUnknown

Remote Monitoring of Home Exercise in Peripheral Arterial Disease

Role: lead

NCT04113057Not ApplicableTerminated

Home-based Walking Program With Smart Devices

Role: lead

NCT02749513Early Phase 1Unknown

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

Role: lead

NCT04018872Phase 2Recruiting

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Role: lead

NCT03511053Not ApplicableCompleted

Epidural Lavage Study for Lumbar Stenosis

Role: lead

NCT04611464Completed

Misoprostol for Spinal Stenosis

Role: lead

NCT00830232Not ApplicableCompleted

Effects of Carotid Stent Design on Cerebral Embolization

Role: lead

NCT01733810Not ApplicableCompleted

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

Role: lead

NCT03221582Phase 4Terminated

Impact of Hepatitis C Therapy and Bone Health

Role: lead

NCT01238536Phase 4Completed

Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)

Role: collaborator

NCT01414387Not ApplicableTerminated

Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting

Role: lead